These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16474399)

  • 61. The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor.
    Hwang LN; Yu Z; Palmer DC; Restifo NP
    Cancer Res; 2006 Jan; 66(2):1132-8. PubMed ID: 16424050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antigen-specific culture of memory-like CD8 T cells for adoptive immunotherapy.
    Litterman AJ; Zellmer DM; LaRue RS; Jameson SC; Largaespada DA
    Cancer Immunol Res; 2014 Sep; 2(9):839-45. PubMed ID: 24852944
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Distinct mechanisms mediate naive and memory CD8 T-cell tolerance.
    Jellison ER; Turner MJ; Blair DA; Lingenheld EG; Zu L; Puddington L; Lefrançois L
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21438-43. PubMed ID: 23236165
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potent induction of long-term CD8+ T cell memory by short-term IL-4 exposure during T cell receptor stimulation.
    Huang LR; Chen FL; Chen YT; Lin YM; Kung JT
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3406-11. PubMed ID: 10725381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MEK inhibition reprograms CD8
    Verma V; Jafarzadeh N; Boi S; Kundu S; Jiang Z; Fan Y; Lopez J; Nandre R; Zeng P; Alolaqi F; Ahmad S; Gaur P; Barry ST; Valge-Archer VE; Smith PD; Banchereau J; Mkrtichyan M; Youngblood B; Rodriguez PC; Gupta S; Khleif SN
    Nat Immunol; 2021 Jan; 22(1):53-66. PubMed ID: 33230330
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state.
    Schietinger A; Delrow JJ; Basom RS; Blattman JN; Greenberg PD
    Science; 2012 Feb; 335(6069):723-7. PubMed ID: 22267581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.
    Crompton JG; Sukumar M; Restifo NP
    Immunol Rev; 2014 Jan; 257(1):264-276. PubMed ID: 24329803
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Divergent fates of antigen-specific CD8
    Chen X; MacNabb BW; Flood B; Blazar BR; Kline J
    Cell Rep; 2021 Nov; 37(6):109991. PubMed ID: 34758311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD8+ T-cell memory in tumor immunology and immunotherapy.
    Klebanoff CA; Gattinoni L; Restifo NP
    Immunol Rev; 2006 Jun; 211():214-24. PubMed ID: 16824130
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.
    Berrien-Elliott MM; Jackson SR; Meyer JM; Rouskey CJ; Nguyen TL; Yagita H; Greenberg PD; DiPaolo RJ; Teague RM
    Cancer Res; 2013 Jan; 73(2):605-16. PubMed ID: 23188506
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.
    Epardaud M; Elpek KG; Rubinstein MP; Yonekura AR; Bellemare-Pelletier A; Bronson R; Hamerman JA; Goldrath AW; Turley SJ
    Cancer Res; 2008 Apr; 68(8):2972-83. PubMed ID: 18413767
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced Cancer.
    Bransi A; Salgado OC; Beffinger M; Milo K; Silina K; Yagita H; Becher B; Knuth A; van den Broek M
    Cancer Immunol Res; 2015 Nov; 3(11):1279-88. PubMed ID: 26141620
    [TBL] [Abstract][Full Text] [Related]  

  • 73. T-cell memory: You must remember this ..
    Bevan MJ; Goldrath AW
    Curr Biol; 2000 May; 10(9):R338-40. PubMed ID: 10801433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Towards 'off-the-shelf' genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells.
    Or-Geva N; Gidron-Budovsky R; Radomir L; Edelstein Y; Singh AK; Sidlik-Muskatel R; Ophir E; Bachar-Lustig E; Reisner Y
    Leukemia; 2018 Apr; 32(4):1039-1041. PubMed ID: 29151584
    [No Abstract]   [Full Text] [Related]  

  • 75. Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes.
    Calzascia T; Loh JM; Di Berardino-Besson W; Masson F; Guillaume P; Burkhardt K; Herrera PL; Dietrich PY; Walker PR
    Glia; 2008 Nov; 56(15):1625-36. PubMed ID: 18551629
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In Vitro Conversion of Activated T Cells into Stem Cell Memory-Like T Cells.
    Kondo T; Imura Y; Ando M; Chikuma S; Yoshimura A
    Methods Mol Biol; 2019; 2048():41-51. PubMed ID: 31396927
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance.
    Alferink J; Schittek B; Schönrich G; Hämmerling GJ; Arnold B
    Int Immunol; 1995 Feb; 7(2):331-6. PubMed ID: 7734426
    [TBL] [Abstract][Full Text] [Related]  

  • 78. IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood.
    Sneller MC; Kopp WC; Engelke KJ; Yovandich JL; Creekmore SP; Waldmann TA; Lane HC
    Blood; 2011 Dec; 118(26):6845-8. PubMed ID: 22067383
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evidence that CD8 T-cell homeostasis and function remain intact during murine pregnancy.
    Norton MT; Fortner KA; Oppenheimer KH; Bonney EA
    Immunology; 2010 Nov; 131(3):426-37. PubMed ID: 20553337
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Resistance to TGFβ suppression and improved anti-tumor responses in CD8
    Brownlie RJ; Garcia C; Ravasz M; Zehn D; Salmond RJ; Zamoyska R
    Nat Commun; 2017 Nov; 8(1):1343. PubMed ID: 29116089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.